Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Winograd

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of the National Cancer Institute|August 21, 1991
Phase I and clinical pharmacological evaluation of aphidicolin glycinateC Sessa, M Zucchetti, E Davoli, et al.
Anti-Cancer Drugs|December 10, 1999
Phase I and pharmacologic study of BMS-181174 given as a 6 h infusion every 4 weeks to patients with advanced solid tumorsA S Planting, J H Schellens, M E van der Burg, et al.
Cancer Research|December 1, 1987
Comparative pharmacokinetics of cisplatin and three analogues in mice and humansM B van Hennik, W J van der Vijgh, I Klein, et al.
Seminars in Oncology|December 1, 1996
Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee studyD Porter, A Boddy, H Thomas, et al.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1996
Bioequivalence assessment of etoposide phosphate and etoposide using pharmacodynamic and traditional pharmacokinetic parametersV Mummaneni, S Kaul, L N Igwemezie, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Cytotoxic effects of anticancer agents on subconfluent and multilayered postconfluent culturesP E Pizao, G J Peters, J Van Ark-Otte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancerJ M Nabholtz, K Gelmon, M Bontenbal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2001
Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancerL Gianni, P Dombernowsky, G Sledge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I studyG G Chabot, J P Armand, C Terret, et al.
British Journal of Cancer|July 17, 1998
Phase I study of the mitomycin C analogue BMS-181174V M Macaulay, K J O'Byrne, J A Green, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of the National Cancer Institute|August 21, 1991
Phase I and clinical pharmacological evaluation of aphidicolin glycinateC Sessa, M Zucchetti, E Davoli, et al.
Anti-Cancer Drugs|December 10, 1999
Phase I and pharmacologic study of BMS-181174 given as a 6 h infusion every 4 weeks to patients with advanced solid tumorsA S Planting, J H Schellens, M E van der Burg, et al.
Cancer Research|December 1, 1987
Comparative pharmacokinetics of cisplatin and three analogues in mice and humansM B van Hennik, W J van der Vijgh, I Klein, et al.
Seminars in Oncology|December 1, 1996
Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee studyD Porter, A Boddy, H Thomas, et al.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1996
Bioequivalence assessment of etoposide phosphate and etoposide using pharmacodynamic and traditional pharmacokinetic parametersV Mummaneni, S Kaul, L N Igwemezie, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Cytotoxic effects of anticancer agents on subconfluent and multilayered postconfluent culturesP E Pizao, G J Peters, J Van Ark-Otte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancerJ M Nabholtz, K Gelmon, M Bontenbal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2001
Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancerL Gianni, P Dombernowsky, G Sledge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I studyG G Chabot, J P Armand, C Terret, et al.
British Journal of Cancer|July 17, 1998
Phase I study of the mitomycin C analogue BMS-181174V M Macaulay, K J O'Byrne, J A Green, et al.
Pageof 4